6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Cystic Fibrosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grenier, C; Grey, VL; Lands, LC | 1 |
1 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Cystic Fibrosis
Article | Year |
---|---|
Total plasma antioxidant capacity in cystic fibrosis.
Topics: Acute Disease; Adolescent; Adult; Antioxidants; Child; Chromans; Cystic Fibrosis; Female; Glutathione; Humans; Lymphocytes; Male; Nutritional Status; Oxidative Stress; Respiratory Mechanics; Serum Albumin; Uric Acid; Vitamin E | 2000 |